Global Loperamide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Loperamide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Loperamide, sold under the brand name Imodium, among others, is a medication used to decrease the frequency of diarrhea. It is often used for this purpose in inflammatory bowel disease and short bowel syndrome.
Loperamide report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Loperamide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Loperamide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Loperamide key manufacturers include Johnson & Johnson, Mylan, Bionpharma, Teva, Perrigo, Sun Pharmaceutical, Aurobindo Pharma and LNK International, etc. Johnson & Johnson, Mylan, Bionpharma are top 3 players and held % sales share in total in 2022.
Loperamide can be divided into Capsule, Tablet, Solution and Granule, etc. Capsule is the mainstream product in the market, accounting for % sales share globally in 2022.
Loperamide is widely used in various fields, such as Hospitals, Clinics and Pharmacies,, etc. Hospitals provides greatest supports to the Loperamide industry development. In 2022, global % sales of Loperamide went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Loperamide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Johnson & Johnson
Mylan
Bionpharma
Teva
Perrigo
Sun Pharmaceutical
Aurobindo Pharma
LNK International
Segment by Type
Capsule
Tablet
Solution
Granule
Hospitals
Clinics
Pharmacies
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Loperamide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Loperamide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Loperamide industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Loperamide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Loperamide introduction, etc. Loperamide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Loperamide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Loperamide report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Loperamide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Loperamide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Loperamide key manufacturers include Johnson & Johnson, Mylan, Bionpharma, Teva, Perrigo, Sun Pharmaceutical, Aurobindo Pharma and LNK International, etc. Johnson & Johnson, Mylan, Bionpharma are top 3 players and held % sales share in total in 2022.
Loperamide can be divided into Capsule, Tablet, Solution and Granule, etc. Capsule is the mainstream product in the market, accounting for % sales share globally in 2022.
Loperamide is widely used in various fields, such as Hospitals, Clinics and Pharmacies,, etc. Hospitals provides greatest supports to the Loperamide industry development. In 2022, global % sales of Loperamide went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Loperamide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Johnson & Johnson
Mylan
Bionpharma
Teva
Perrigo
Sun Pharmaceutical
Aurobindo Pharma
LNK International
Segment by Type
Capsule
Tablet
Solution
Granule
Segment by Application
Hospitals
Clinics
Pharmacies
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Loperamide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Loperamide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Loperamide industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Loperamide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Loperamide introduction, etc. Loperamide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Loperamide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
